Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Beck

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Oncology Research|January 1, 1995
A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agentsS Hashimoto, M K Danks, S Chatterjee, et al.
Advances in Enzyme Regulation|January 1, 1993
Drug resistance associated with altered DNA topoisomerase IIW T Beck, M K Danks, J S Wolverton, et al.
Cancer Research|June 1, 1996
Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase IIH Kusumoto, Q E Rodgers, F Boege, et al.
Progress in Clinical and Biological Research|January 1, 1986
Cross-resistance patterns and antigen expression in Vinca alkaloid- and other multiple drug-resistant human leukemic cell linesW T Beck, M K Danks, M C Cirtain, et al.
Cancer Research|June 15, 1987
Preclinical evaluation of illudins as anticancer agentsM J Kelner, T C McMorris, W T Beck, et al.
Oncology Research|January 1, 1992
Structure-activity studies of amsacrine analogs in drug resistant human leukemia cell lines expressing either altered DNA topoisomerase II or P-glycoproteinB Granzen, D E Graves, B C Baguley, et al.
Biochemical and Biophysical Research Communications|June 30, 1988
Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastineW T Beck, M C Cirtain, C J Glover, et al.
Biochemistry|November 29, 1988
Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26M K Danks, C A Schmidt, M C Cirtain, et al.
Cancer Genetics and Cytogenetics|October 1, 1993
Loss of tumorigenicity in a methotrexate-resistant human leukemia cell lineA B Hill, J M Trent, F H Thompson, et al.
Cytometry|February 1, 1995
Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopyS D Baker, R M Wadkins, C F Stewart, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Oncology Research|January 1, 1995
A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agentsS Hashimoto, M K Danks, S Chatterjee, et al.
Advances in Enzyme Regulation|January 1, 1993
Drug resistance associated with altered DNA topoisomerase IIW T Beck, M K Danks, J S Wolverton, et al.
Cancer Research|June 1, 1996
Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase IIH Kusumoto, Q E Rodgers, F Boege, et al.
Progress in Clinical and Biological Research|January 1, 1986
Cross-resistance patterns and antigen expression in Vinca alkaloid- and other multiple drug-resistant human leukemic cell linesW T Beck, M K Danks, M C Cirtain, et al.
Cancer Research|June 15, 1987
Preclinical evaluation of illudins as anticancer agentsM J Kelner, T C McMorris, W T Beck, et al.
Oncology Research|January 1, 1992
Structure-activity studies of amsacrine analogs in drug resistant human leukemia cell lines expressing either altered DNA topoisomerase II or P-glycoproteinB Granzen, D E Graves, B C Baguley, et al.
Biochemical and Biophysical Research Communications|June 30, 1988
Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastineW T Beck, M C Cirtain, C J Glover, et al.
Biochemistry|November 29, 1988
Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26M K Danks, C A Schmidt, M C Cirtain, et al.
Cancer Genetics and Cytogenetics|October 1, 1993
Loss of tumorigenicity in a methotrexate-resistant human leukemia cell lineA B Hill, J M Trent, F H Thompson, et al.
Cytometry|February 1, 1995
Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopyS D Baker, R M Wadkins, C F Stewart, et al.
Pageof 11